Pharmacogenetics may influence tacrolimus daily dose, but not urinary tubular damage markers in the long-term period after renal transplantation
Background: The primary goal of this study was to evaluate the influence of cytochrome P450 (CYP) 3A5 (6986A>G) and ABCB1 (3435C>T) polymorphisms on tacrolimus (TAC) dosage regimen and exposure. Second, we evaluated the influence of TAC dosage regimen and the tested polymorphisms on renal oxid...
Main Authors: | Stefanović Nikola Z., Cvetković Tatjana P., Veličković-Radovanović Radmila M., Jevtović-Stoimenov Tatjana M., Vlahović Predrag M., Stojanović Ivana R., Pavlović Dušica D. |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Medical Biochemists of Serbia, Belgrade
2015-01-01
|
Series: | Journal of Medical Biochemistry |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2015/1452-82581504422S.pdf |
Similar Items
-
Effect of the Interrelation between CYP3A5 Genotype, Concentration/Dose Ratio and Intrapatient Variability of Tacrolimus on Kidney Graft Function: Monte Carlo Simulation Approach
by: Nikola Stefanović, et al.
Published: (2021-11-01) -
Interactions between Tacrolimus and Metronidazole in a renal transplant patient
by: Catic-Djordjevic Aleksandra, et al.
Published: (2012-10-01) -
Effect of ABCB1 (3435C>T) and CYP3A5 (6986A>G) genes polymorphism on tacrolimus concentrations and dosage requirements in liver transplant patients
by: Marwa Helal, et al.
Published: (2017-07-01) -
The Impact of CYP3A4*22 on Tacrolimus Pharmacokinetics and Outcome in Clinical Practice at a Single Kidney Transplant Center
by: Emaad Abdel-Kahaar, et al.
Published: (2019-09-01) -
<i>CYP3A5*3</i> and <i>CYP3A4*22</i> Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach
by: Zeyar Mohammed Ali, et al.
Published: (2023-11-01)